Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-25 @ 4:06 AM
NCT ID:
NCT04895202
Eligibility Criteria:
Inclusion Criteria:
1. Signed informed consent
2. Adult patients with a documented diagnosis of SPMS with inflammatory disease activity who are going to be treated with Siponimod under routine medical care and in accordance with the Swiss label
3. Patient willing and able to complete the questionnaires
Exclusion Criteria:
1. Patients treated outside of the approved Swiss label for Siponimod
2. Prior treatment or already ongoing treatment with Siponimod
3. Use of investigational drugs during the study, OR within 3 months before enrollment, OR within 5 half-lives of investigational drug before enrollment, OR until the expected pharmacodynamic effect has returned to baseline, whichever is longer
4. Subjects who are not able to provide consent due to incapable judgement
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04895202
Study Brief:
Protocol Section:
NCT04895202